VEGFA and neoplasm: It inhibits multiple RTKs and disrupts the signaling pathways that promote tumor growth and angiogenesis by regulating VEGFRs, FGFRs, PDGFRs, etc. Bevacizumab is a humanized monoclonal antibody against VEGF-A that binds directly to VEGF and reduces tumor angiogenesis (140).